🟢 Eupraxia Pharmaceuticals is trading 6% up today amid a broader U.S. technology-stock rebound

Eupraxia Pharmaceuticals is trading at $7.01, up 5.89%, alongside a broader rebound in U.S. technology stocks.

• The Nasdaq is up 0.96%, and the S&P 500 is up 0.44%.
• Eupraxia had previously announced that RESOLVE trial research would be presented at UEG Week, including an oral session scheduled for October 19; the presentation was publicized before this session.
• No new company-specific announcement explaining the move was found; available evidence points to broader market sentiment rather than a confirmed company-specific catalyst.